GlassScriptPhysician profile
Virgil P Secasanu
NPI 1417290982
$6,063.13
in general payments reported to CMS, 2019-2025
13 companies · $316 in 2025
The $316 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $412 · 2020: $248 · 2021: $137 · 2022: $782 · 2023: $185 · 2024: $3,984 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $1,261 · Food and Beverage: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $1,261.28 |
| Food and Beverage | $723.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,605.03 | 2022-2024 | |
| Boston Scientific Corporation | $609.90 | 2019-2020 | |
| Inari Medical, INC. | $297.54 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pulmonx Corporation | $152.96 | 2022-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Ethicon INC. | $124.40 | 2021 | |
| Medtronic, INC. | $104.35 | 2023 | Illumisite |
| Olympus America INC. | $44.94 | 2023 | Spiration Valve System |
| Amgen INC. | $26.03 | 2022 | |
| Olympus Corporation of The Americas | $25.76 | 2019 | |
| Genzyme Corporation | $23.64 | 2020 | |
| Mylan Specialty L.P. | $19.60 | 2023 | Yupelri |
| Glaxosmithkline, LLC. | $16.52 | 2023 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $12.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Virgil Secasanu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.